A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques
Open Access
- 7 December 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (1) , 333-345
Abstract
The delivery of drugs to specific target tissues and cells in the brain poses a significant challenge in brain therapeutics, primarily due to limited understanding of how nanoparticle (NP) properties influence drug biodistribution and off-target organ accumulation. This study addresses the limitations of previous research by using various predictive models based on collection of large data sets of 403 data points incorporating both numerical and categorical features. Machine learning techniques and comprehensive literature data analysis were used to develop models for predicting NP delivery to the brain. Furthermore, the physicochemical properties of loaded drugs and NPs were analyzed through a systematic analysis of pharmacodynamic parameters such as plasma area under the curve. The analysis employed various linear models, with a particular emphasis on linear mixed-effect models (LMEMs) that demonstrated exceptional accuracy. The model was validated via the preparation and administration of two distinct NP formulations via the intranasal and intravenous routes. Among the various modeling approaches, LMEMs exhibited superior performance in capturing underlying patterns. Factors such as the release rate and molecular weight had a negative impact on brain targeting. The model also suggests a slightly positive impact on brain targeting when the drug is a P-glycoprotein substrate.Keywords
This publication has 53 references indexed in Scilit:
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetinArchives of Pharmacal Research, 2011
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- Nasal Delivery of High Molecular Weight DrugsMolecules, 2009
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseBMC Neuroscience, 2008
- Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbitsInternational Journal of Pharmaceutics, 2008
- A study of rivastigmine liposomes for delivery into the brain through intranasal routeActa Pharmaceutica, 2008
- UEA I-bearing nanoparticles for brain delivery following intranasal administrationInternational Journal of Pharmaceutics, 2007
- Pharmacokinetics and Pharmacodynamics of a New Intranasal Midazolam Formulation in Healthy VolunteersAnesthesia & Analgesia, 2006
- Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating densityJournal of Controlled Release, 2004